Life Technologies Events

Life Technologies events can be found at the Life Technologies web site. We hope to see you at those events as well.

Show Events

• • • • • • • • • • • • • • • • • • • •

Q1 2013

Molecular Medicine Tri-Conference

11 - 15 FEB 2013
San Francisco, CA, USA

Life Technologies booth #307

POSTER: Frequency and Co-occurrence of MAPK and PI3K Pathway Driver Mutations to Guide Single-agent and Combination Therapies: An Analysis of Next Generation Sequence Data from 2,700 Patients
PRESENTER: Dr. Emma Bowden

ROUNDTABLE #47:
13 FEB 2013 | 5:20 pm
Leveraging TCGA and NGS data for Cancer Biomarker Discovery and Clinical Population Selection
MODERATORS: Dr. Emma Bowden,
Matt Anstett

Show Web Site

• • • • • • • • • • • • • • • • • • • •

NGS for Drugs, Patients and Clinical Trials

21 - 22 MAR 2013
San Diego, CA, USA

POSTER: Analysis of 3,000 Cancer Exomes to Identify Novel Cancer Drivers and Therapeutic Opportunities
PRESENTER: Nickolay Khazanov

Show Web Site

• • • • • • • • • • • • • • • • • • • •

AACR Annual Meeting

06 - 10 APR 2013
Washington, DC, USA

Show Web Site

Visit our showroom

BOOTH #2357

• • • • • • • • • • • • • • • • • •

06 APR 2013 | 6:30 pm
Applications in Cancer Research using Life Technologies Solutions
Renaissance, Washington DC

RSVP NOW

• • • • • • • • • • • • • • • • • •

08 APR 2013 | 11:00 am
RALLY FOR MEDICAL RESEARCH
Carnegie Library Grounds

MORE INFO

• • • • • • • • • • • • • • • • • •

09 APR 2013 | 8:00 am
POSTER #2897
Hall A-C, Section 23
Discovery and characterization of driver MAPK and PI3K pathway mutations in tumors and association with drug response in cell lines
PRESENTER: Dr. Sean Eddy

POSTER #3173
Hall A-C, Section 33
High-throughput, systematic analysis of paired-end next-generation sequencing data to characterize the gene fusion landscape in cancer
PRESENTER: Armand Bankhead

• • • • • • • • • • • • • • • • • • • •

ASCO Annual Meeting

31 MAY - 04 JUN 2013
Chicago, IL, USA

Featured Exhibitor
BOOTH #17020

Show Web Site

More to come...

Biotech Showcase

09–11 JAN 2012
San Francisco, CA, USA
Parc 55 Wyndham San Francisco - Union Square

Show Web Site

• • • • • • • • • • • • • • • • • • • •

BIO-Europe Spring

17–21 MAR 2012
Amsterdam, The Netherlands
RAI

Show Web Site

PANEL:
MON 17:15-18:15
Level 1, Room E104
The opportunity of community drug development partnerships for personalized oncology and drug development
MODERATOR: John Freshley

• • • • • • • • • • • • • • • • • • • •

AACR Annual Meeting

31 MAR – 04 APR 2012
Chicago, IL, USA
McCormick Place

Show Web Site

BOOTH #4443

POSTERS:
TUE 8:00am–12:00pm
Molecular Targets and Pathways 1 | Clinical Research 15 | Section 25

#3664 | Breast cancer companion diagnostic platform based on objectively defined tumor co-expression patterns stratifies multiple clinical and therapeutic endpoints comparison to existing molecular subtyping definitions
PRESENTER: Seth Sadis

#3665 | An EMT gene expression diagnostic predicts resistance to EGFR and MEK-targeted therapies in cell lines and patients
PRESENTER: Sean Eddy

AACR Mechanisms of Resistance

09–12 MAY 2012
San Diego, CA, USA

Show Web Site

POSTER:
10 MAY 2012 | 2:00 - 4:30 pm
A19 | A qPCR assay, OncoScore Colon predicts resistance to cetuximab in formalin-fixed, paraffin-embedded colorectal cancer tissue independent of KRAS status
PRESENTER: Sean Eddy

• • • • • • • • • • • • • • • • • • • •

GLBIO 2012
INDUSTRY TRACK SPONSOR

15–17 MAY 2012
Ann Arbor, MI, USA
Michigan League

Show Web Site

POSTERS:
15 MAY 2012 |5:30 - 7:30 pm
A07 | Discovery of Novel Cancer Genes through Application of Clinical Metadata Ontology
PRESENTER: Jeff Bonevich

A06 | Evaluating Predictive Drug Biomarkers Across 31,000 + Clinical Samples
PRESENTER: Ross Patterson

INDUSTRY TRACK PRESENTATION:
16 MAY 2012 | 10:10 - 10:30 am
Compendia Bioscience
PRESENTER: Chris Gates

• • • • • • • • • • • • • • • • • • • •

ASCO Annual Meeting

01–05 JUN 2012
Chicago, IL, USA
McCormick Place

Show Web Site

BOOTH #23088

EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics

06-09 NOV 2012
Dublin, Ireland

BOOTH A9

POSTERS:
09 NOV 2012 | 08:30 - 10:30

#492 | Frequency and Co-occurrence of MAPK and PI3K Pathway Driver Mutations to Guide Single-agent and Combination Therapies: an Analysis of Next Generation Sequence Data From 2700 Patients
PRESENTER: Dr. Emma Bowden

#430 | Analysis of 2,700 Cancer Exomes to Identify Novel Cancer Drivers and Therapeutic Opportunities
PRESENTER: John Freshley

Show Web Site

• • • • • • • • • • • • • • • • • • • •

BIO-Europe 2012

12-14 NOV 2012
Hamburg, Germany

Monday, 12 NOV 2012
09:00–10:30
Level 2, Room D
Personalized oncology and next gen cancer drug development
MODERATOR: John Freshley

Show Web Site

• • • • • • • • • • • • • • • • • • • •

Second Annual TCGA Scientific Symposium

27-28 NOV 2012
Crystal City, VA, USA

ORAL PRESENTATION:
28 NOV 2012 | 9:55 - 10:10 am

POSTER: 27 NOV 2012 | 1:30 - 3:00 pm

Analysis of 3,000 Cancer Exomes to Identify Novel Cancer Drivers and Therapeutic Opportunities PRESENTER: Dr. Nickolay Khazanov

Show Web Site

AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics

12–16 NOV 2011
San Francisco, CA, USA | Moscone Center West

EXHIBITOR | Booth #300

PRESENTATION | 15 NOV 2011
2:30 – 4:30 pm

Concurrent Session 7: Challenges in Genomic-based Characterization of Tumors

Target discovery with Oncomine: Discovering new targets and positioning old targets by integrative analysis of 10,000’s of tumor genomes and transcriptomes.

SPEAKER :: Dr. Daniel Rhodes

POSTER | 14 NOV 2011
Session B | 12:30 PM - 2:30 pm
B27 | West Hall, Level One, Moscone Center West

OncoPredictor: High copy number gain of ERBB2 occurs in 1% of lung cancer patients and predicts sensitivity to lapatinib in lung cancer cell lines

PRESENTER :: Dr. Sean Eddy

Show Web Site

The Cancer Genome Atlas' 1st Annual Scientific Symposium: Enabling Cancer Research Through TCGA

17–18 NOV 2011
National Harbor, MD, USA

PRESENTATION | 17 NOV 2011
Session 7: Oncomine - Chesapeake 2&3
PRESENTER :: Dr. Paul Williams

POSTER | #81

Show Web Site

CTRC-AACR San Antonio Breast Cancer Symposium

6–10 DEC 2011
San Antonio, TX, USA | Henry B. Gonzalez Convention Center

EXHIBITOR | Booth #438

POSTER | 07 DEC 2011
5:00-7:00 pm | P1-07-04
Gene Expression Module Biomarkers To Stratify Multiple Clinical and Therapeutic Endpoints for Universal Breast Cancer Companion Diagnostic.

PRESENTER :: Dr. Seth Sadis

Show Web Site

AACR Translation of the Cancer Genome
CONFERENCE SPONSOR
15–18 OCT 2011
San Francisco, CA, USA | Hyatt Regency San Francisco

POSTER Session B | 17 OCT 2011
5–7 pm
Integrated analysis of patient level genetic aberrations in human cancer.

PRESENTER :: Chris Gates

Show Web Site

ASCO-NCI-EORTC Annual Meeting on "Molecular Markers in Cancer"
27–29 OCT 2011

PRESENTATION | 26 OCT 2011
13:25–13:35
SESSION 2 - Regulatory Issues and Identifying Resources Stories of Success & Struggle
Diagnostic Approaches to Identify Predictive Subgroups

SPEAKER :: Dr. Daniel Rhodes

Show Web Site

ASCO Breast Cancer Symposium
8–10 SEP 2011
San Francisco, CA, USA | Marriott Marquis
Poster Session C | 9 SEP 2011
12:00 – 1:30 pm | D14
Presented by Seth Sadis, PhD
Association of gene expression module biomarkers with clinical and therapeutic endpoints and their use with a universal companion diagnostic assay.

Show Web Site

BioPharm America
7–11 SEP 2011
Boston, MA, USA | Westin Boston Waterfront
Panel: Understanding the Forces of Next Gen Sequencing in the Context of Personalized Medicine
Moderator: Dr. Daniel Rhodes

ASCO Annual Meeting
EXHIBITOR | 3–7 JUN 2011
Chicago, IL, USA | McCormick Place
Booth #25018

Show Web Site

Keystone Symposia: Changing Landscape of the Cancer Genome
SPEAKER | 25 JUN 2011
2:30 - 4:30 pm
Daniel R. Rhodes
Focal Amplification of Existing Kinase Inhibitor Targets Identified from TCGA Data and Integrative Analysis
Boston, MA

Show Web Site

BIO International Convention
EXHIBITOR | 27–30 JUN 2011
Washington, DC
Michigan Pavilion #1337 - Hall A

Show Web Site

AACR Annual Meeting
EXHIBITOR | 2–6 APR 2011
Orlando, FL, USA | Orange County Convention Center
Booth #1265

Molecular Medicine Tri-Conference

CONFERENCE SPONSOR
23–25 JAN 2011
San Francisco, CA, USA | Moscone North
Booth #301

Wednesday, FEB 23 | 12:40 pm
Tumor Segregation Panels: FFPE RT-PCR Assays for Molecular Sub-Typing and Rapid Companion Diagnostic Development
PRESENTER :: Dr. Daniel Rhodes

Friday, FEB 25 | 10:05 am
OncoPredictor: A System for Identifying Clinically Relevant Biomarkers from Large Scale Cell Line Profiling
PRESENTER :: Dr. Daniel Rhodes

Show Web Site

8th Annual Cancer Drugs Research and Development Conference

27–28 JAN 2011
San Diego, CA, USA | Paradise Point Resort & Spa

Friday, JAN 28 | 9:00 am
Genomic Biomarkers to Predict Cancer Drug Response Identified from Large-Scale Cell Line Screening and Parallel Preclinical and Clinical Tumor Biomarker Databases
PRESENTER :: Dr. Seth Sadis

Show Web Site